Skip to main content

Table 3 The genotypes of MUC5B promoter polymorphism as regards gender among the 3 studied groups

From: A preliminary study: MUC5B promoter polymorphism and its association with IPF

Genotype Female gender Male gender P value
IPF patients (group I)    
GT and TT 13 (50%) 13 (50%) 0.109
GG 4 (25%) 12 (75%)  
Other ILD patients (group II)    
GT and TT 14 (82.4%) 3 (17.6%) 0.647
GG 23 (76.7%) 7 (23.3%)  
Control subjects (group III)    
GT and TT 6 (75%) 2 (25%) 1.000
GG 24 (75%) 8 (25%)